5 FREQUENTLY ASKED QUESTIONS ABOUT THE CLASS ACTION against TANDEM DIABETES

If you suffered losses in Tandem Diabetes stock contact Tandem Diabetes stock loss lawyer Timothy L. Miles

introduction to the THE CLASS ACTION AGAINST TANDEM DIABETES

The class action against Tandem Diabetes seeks to represent purchasers or acquirers of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) securities between August 3, 2022 and November 2, 2022, inclusive (the “Class Period”).  Captioned Lowe v. Tandem Diabetes Care, Inc., No. 23-cv-01657 (S.D. Cal.), the class action against Tandem Diabetes charges Tandem Diabetes and certain of its top executive officers with violations of the Securities Exchange Act of 1934.
​
If you suffered losses in Tandem Diabetes stock and wish to serve as lead plaintiff in the class action against Tandem Diabetes, please provide your information below. You can also ​contact Tandem Diabetes Stock Loss Lawyer Timothy L. Miles by calling 855/846-6529 or via e-mail at [email protected] or by submitting a contact form. Lead plaintiff motions for the class action against Tandem Diabetes must be filed with the court no later than November 7, 2023.

​Read on for answers to five frequently asked questions about the class action against Tandem Diabetes.

CAN A NON-U.S. INVESTOR SERVE AS LEAD PLAINTIFF IN THE the CLASS ACTION against TANDEM DIABETES IF THEY SUFFERED LOSSES IN TANDEM DIABETES?

Yes, courts in the U.S. have consistently recognized that non-U.S. investors, many of whom have substantial holdings, are adequate lead plaintiffs and have the same right to move for lead plaintiffs as U.S. investors.  Thus, if a non-U.S. investor suffered losses in Tandem Diabetes stock, they may move the Court to be appointed lead plaintiff in the class action against Tandem Diabetes. 

IF I SUFFERED LOSSES IN TANDEM DIABETES STOCK, WHAT ARE THE BENEFITS OF SERVING AS LEAD PLAINTIFF IN THE TANDEM DIABETES CLASS ACTION LAWSUIT?

Serving as a Lead Plaintiff in the Tandem Diabetes class action lawsuit​ has several advantages and important benefits including:

• A Lead Plaintiff is able to negotiate more competitive attorney fees and reduce other litigation costs by actively monitoring the class counsel.
• Lead Plaintiff has the benefit of being able to manage the litigation primarily by overseeing and monitoring the progress of the action and the efforts of counsel, and being able to review and comment on important filings and other documents pertaining to the prosecution of the action.
• There is no financial risk in serving as a Lead Plaintiff because Lead Counsel advances all costs and expenses incurred it the prosecution of the case and will be reimbursed only if there is a successful settlement or judgment recovery on behalf of the class.
• Lead Plaintiff has the benefit involved and active in all negotiations relating to any settlement.
• Lead Plaintiffs that continue owning the stock of the defendant will enjoy the long-term benefits from governance reform resulting from the litigation. 

Thus, there are numerous benefits and other advantages to serving as lead plaintiff in a class action against Tandem Diabetes if you suffered losses in Tandem Diabetes stock. ​

CAN I BE APPOINTED LEAD PLAINTIFF IN THE TANDEM DIABETES CLASS ACTION LAWSUIT IF I PURCHASED SHARES OUTSIDE OF THE CLASS PERIOD?

No.  Even if you suffered losses in Tandem Diabetes stock, if you purchased or sold securities outside of the Class period, you will not be able to participate in the Tandem Diabetes class action lawsuit​.​

CAN I BE LEAD PLAINTIFF IN THE TANDEM DIABETES CLASS ACTION LAWSUIT IF I AM LEAD PLAINTIFF IN ANOTHER CASE?

​​Yes, unless you have been a lead plaintiff in more than five securities class actions during any three-year period which is expressly prohibited by the securities laws. Otherwise, if you suffered losses in Tandem Diabetes stock, you may move to be appointed lead plaintiff in the Tandem Diabetes class action lawsuit​.

HOW WAS THE CLASS PERIOD DETERMINED IN THE TANDEM DIABETES CLASS ACTION LAWSUIT?

In a securities fraud class action, the class period refers to a period of time in which it is alleged the price of the company’s stock was artificially inflated due to false and misleading statements made by company executives.  The class period starts when the company makes an untrue statement of material fact about the company or fails to disclose a material fact necessary to render other statements not misleading.  The class period ends when the truth is revealed to the investing public through a corrective disclosure.  
 
In order to be a part of the class in the Tandem Diabetes class action lawsuit​, you must have suffered losses in Tandem Diabetes stock by purchasing during the class period when it is alleged the price of the stock was artificially inflated to be included in the Tandem Diabetes class action lawsuit​.  ​

CONTACT A TANDEM DIABETES STOCK LOSS LAWYER TODAY IF YOU SUFFERED LOSSES IN TANDEM DIABETES STOCK ABOUT A TANDEM DIABETES CLASS ACTION LAWSUIT

​If you suffered losses in Tandem Diabetes stock, contact Tandem Diabetes stock loss lawyer Timothy L. Miles today for a free case evaluation about a Tandem Diabetes class action lawsuit​. Call today and see what a Tandem Diabetes stock loss lawyer can do for you if you suffered losses in Tandem Diabetes stock.

Tandem Diabetes stock loss lawyer Timothy L. Miles

Nashville attorney Timothy L. Miles is a nationally recognized shareholder rights attorney raised in Nashville, Tennessee. Mr. Miles has dedicated his career to representing shareholders, employees, and consumers in complex class-action litigation. Whether serving as lead, co-lead, or liaison counsel, Mr. Miles has helped recover hundreds of millions of dollars for defrauded investors, shaped precedent-setting decisions, and delivered real corporate governance reforms. Judges and peers have repeatedly recognized Mr. Miles relentless advocacy for the underdog, as well as his unbendable ethical standards. Mr. Miles was recently selected by Martindale-Hubbell® and ALM as a 2022 Top Ranked Lawyer, 2022 Top Rated Litigator. and a 2022 Elite Lawyer of the South. Mr. Miles also maintains the AV Preeminent Rating by Martindale-Hubbell®, their highest rating for both legal ability and ethics. Mr. Miles is a member of the prestigious Top 100 Civil Plaintiff Trial Lawyers: The National Trial Lawyers Association, 6Class Action:  Class Action: Top National Trial Lawyers, National Trial Lawyers Association (2023), a superb rated attorney by Avvo, a recipient of the Lifetime Achievement Award by Premier Lawyers of America (2019) and recognized as a Distinguished Lawyer, Recognizing Excellence in Securities Law, by Lawyers of Distinction (2019); a Top Rated Litigator by Martindale-Hubbell® and ALM  (2019-2022); America's Most Honored Lawyers 2020; Top 1% by America's Most Honored (2020-2022).  Mr. Miles has published over sixty articles on various issues of the law, including class actions, whistleblower cases, products liability, civil procedure, derivative actions, corporate takeover litigation, corporate formation, mass torts, dangerous drugs, and more.  Please visit our website or call for free anytime.

CONTACT                                                      
The Law Offices of Timothy L. Miles
Tapestry at Brentwood Town Center
300 Centerview Dr., #247
Brentwood, TN 37027
Phone: (855) 846-6529